Saudi Arabia - English - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

ebewe pharma, austria - paclitaxel - concentrate for solution for infusion - 6 mg/ml

Israel - English - Ministry of Health

novartis israel ltd - paclitaxel - concentrate for solution for infusion - paclitaxel 6 mg/ml - paclitaxel - paclitaxel - paclitaxel is indicated alone or in combination, for the treatment of advanced carcinoma of the ovary. for the treatment of metastatic breast cancer after failure of combination chemotherapy. prior therapy should have included an anthracycline unless clinically containdicated. paclitaxel is indicated for the adjuvant treatment of node-positive breast cancer administered sequentially to standard doxorubicin-containing combination chemotherapy. advanced non small cell lung cancer: paclitaxel associated with cisplatinum is indicated for the treatment of non small cell lung cancer in patients who are not candidates for potentially curative surgery and/or radiation therapy. kaposis's sarcoma: paclitaxel is indicated in the second-line treatment of aids related kaposi's sarcoma

Ireland - English - HPRA (Health Products Regulatory Authority)

ebewe pharma ges.m.b.h nfg. kg - paclitaxel - concentrate for soln for inf - 6 mg/ml

Singapore - English - HSA (Health Sciences Authority)

sandoz singapore pte. ltd. - paclitaxel - infusion, solution concentrate - 6mg/ml - paclitaxel 6mg/ml

Saudi Arabia - English - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

ebewe pharma, austria - paclitaxel - concentrate for solution for infusion - 6 mg/ml

Ireland - English - HPRA (Health Products Regulatory Authority)

ebewe pharma ges.m.b.h nfg. kg - paclitaxel - concentrate for soln for inf - 6 mg/ml

Saudi Arabia - English - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

ebewe pharma, austria - paclitaxel - concentrate for solution for infusion - 6 mg/ml

Saudi Arabia - English - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

ebewe pharma, austria - paclitaxel - concentrate for solution for infusion - 6 mg/ml

South Africa - English - South African Health Products Regulatory Authority (SAHPRA)

adcock ingram critical care (pty) ltd - infusion (parenteral) - see ingredients - each 5,0 ml suspension contains paclitaxel 30,0 mg

South Africa - English - South African Health Products Regulatory Authority (SAHPRA)

adcock ingram critical care (pty) ltd - infusion (parenteral) - see ingredients - each16,6 ml suspension contains paclitaxel 100,0 mg